id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-294585-dl5v9p50	Klein, H. G.	Pathogen‐reduction methods: advantages and limits	2009-02-13		.txt	text/plain	4522	182	36	Pathogen-inactivation of components containing red blood cells presents a particularly challenging dilemma. S303 (Helinx), a small molecule designed for pathogeninactivation treatment of red blood cells, is an alkylating agent derived from a quinacrine mustard that belongs to a class of 'frangible anchor linker effectors' (FRALE) compounds.	cache/cord-294585-dl5v9p50.txt	txt/cord-294585-dl5v9p50.txt
